Manganese-Induced Neurotoxic Effects Research in South Africa
Project Number7R01ES026891-06
Former Number5R01ES026891-05
Contact PI/Project LeaderRACETTE, BRAD A
Awardee OrganizationST. JOSEPH'S HOSPITAL AND MEDICAL CENTER
Description
Abstract Text
Abstract
Manganese (Mn) is an established neurotoxicant that affects motor and cognitive brain pathways. This
proposal builds on a growing body of Mn neurotoxicity research generated by our investigative team and
others. Despite these important contributions to studying the health effects of Mn exposure in vivo, defining
the associated neuropathology is essential to understand mechanisms of injury and to characterize dose-
response relations that will inform regulatory policy. These types of studies are extremely challenging due to
the difficulty in acquiring human brain tissue and quantifying lifetime exposure to Mn in the same subjects.
Over the last seven years, we have developed a collaboration with the University of the Witwatersrand in
Johannesburg, South Africa using the only population-wide, occupational autopsy program in the world.
Through this collaboration we have conducted novel preliminary Mn neuropathology studies that support the
aims in this proposal. Our data suggest that chronic, low-level Mn exposure in these mines is associated with
lower neuronal density and higher microglial/astrocyte ratios in the caudate and putamen, indicating that Mn
exposure may cause astrocytic dysfunction which in turn induces a pro-inflammatory neurotoxic state in the
corpus striatum (caudate, putamen, globus pallidus), driven by the activation of microglia. Astrocytic
dysfunction is likely attributable, in part, to dysregulation of several key mitochondrial proteins induced by Mn
exposure. However, our preliminary studies also suggest that Mn mineworkers, with high MRI signal intensity
on T1 MRI, have similar corpus striatal tissue Mn concentrations, but possibly lower Fe concentrations, than
non-Mn mineworkers. In this proposal, we will follow-up on these preliminary data by collecting brains from
deceased Mn mineworkers with contemporaneous Mn exposures and appropriately matched non-Mn
mineworkers. We will use unbiased stereologic methods to quantify neurons, astrocytes, and microglia in the
caudate, putamen, globus pallidus, substantia nigra pars compacta (SNpc), and olfactory bulbs in both groups
of workers and investigate the overall and dose-response associations between these counts and cumulative
Mn exposure. We will also use immunofluorescence microscopy to quantify targeted astrocytic mitochondrial
proteins and inductively coupled plasma-mass spectrometry to compare corpus striatal Mn and Fe
concentrations between groups. This highly innovative study will provide a rare opportunity to advance the
field of Mn neurotoxicity by investigating the neuropathologic effects of chronic Mn exposure.
Public Health Relevance Statement
Project Narrative
In this application, we propose to investigate the neuropathologic effects associated with low-level occupational
manganese (Mn) exposure in South African Mn mineworkers. This study will build substantially on prior work
by us and others toward understanding the health effects of a common occupational and environmental
exposure and will inform environmental regulatory policy.
National Institute of Environmental Health Sciences
CFDA Code
113
DUNS Number
131606022
UEI
SKX6AXF9ZTM3
Project Start Date
25-March-2023
Project End Date
31-August-2024
Budget Start Date
25-March-2023
Budget End Date
31-August-2024
Project Funding Information for 2021
Total Funding
$623,956
Direct Costs
$470,625
Indirect Costs
$153,331
Year
Funding IC
FY Total Cost by IC
2021
National Institute of Environmental Health Sciences
$623,956
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01ES026891-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01ES026891-06
Patents
No Patents information available for 7R01ES026891-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01ES026891-06
Clinical Studies
No Clinical Studies information available for 7R01ES026891-06
News and More
Related News Releases
No news release information available for 7R01ES026891-06
History
No Historical information available for 7R01ES026891-06
Similar Projects
No Similar Projects information available for 7R01ES026891-06